(Q38398139)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Aleksandr Togo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Sergey Orlov

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Aglaya G Iyevleva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Artiom N Poltoratskiy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Alexandr O Ivantsov

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Igor S Polyakov

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Dmitry E Matsko

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Viktor I Novik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Evgeny N Imyanitov

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

13 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

370-376

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

What went wrong with Iressa?

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

ALK inhibition for non-small cell lung cancer: from discovery to therapy in record time

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

The positive impact of cytological specimens for EGFR mutation testing in non-small cell lung cancer: a single South East Asian laboratory's analysis of 670 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR gene mutation study in cytology specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

The application of molecular diagnostic studies interrogating EGFR and KRAS mutations to stained cytologic smears of lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Rapid and efficient detection of EGFR mutations in problematic cytologic specimens by high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Cytomorphologic features of advanced lung adenocarcinomas tested for EGFR and KRAS mutations: a retrospective review of 50 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLD-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Detection of epithelial growth factor receptor mutations in cerebrospinal fluid from patients with lung adenocarcinoma suspected of neoplastic meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR mutations detection on liquid-based cytology: is microscopy still necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Detection of EGFR mutations in archived cytologic specimens of non-small cell lung cancer using high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Molecular pathology of lung cancer: key to personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Measurement of DPD and TS transcripts aimed to predict clinical benefit from fluoropyrimidines: confirmation of the trend in Russian colorectal cancer series and caution regarding the gene referees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EML4-ALK: honing in on a new target in non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Detection of anaplastic lymphoma kinase (ALK) gene rearrangement in non-small cell lung cancer and related issues in ALK inhibitor therapy: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

COLD-PCR enrichment of rare cancer mutations prior to targeted amplicon resequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21281

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCY.21281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408463%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference